phosphatidylcholines has been researched along with Splenic Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chanock, SJ; Figg, WD; Gupta, R; Hill, S; Jarosinski, P; Piscitelli, S; Pizzo, PA; Walsh, TJ; Whitcomb, P | 1 |
Philips, DL; Sallah, S; Sallah, W; Semelka, RC; Vainright, JR | 1 |
1 trial(s) available for phosphatidylcholines and Splenic Diseases
Article | Year |
---|---|
Safety, tolerance, and pharmacokinetics of amphotericin B lipid complex in children with hepatosplenic candidiasis.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Candidiasis; Child; Child, Preschool; Drug Combinations; Female; Humans; Liver Diseases; Male; Phosphatidylcholines; Phosphatidylglycerols; Splenic Diseases | 1997 |
1 other study(ies) available for phosphatidylcholines and Splenic Diseases
Article | Year |
---|---|
Amphotericin B lipid complex for the treatment of patients with acute leukemia and hepatosplenic candidiasis.
Topics: Acute Disease; Adult; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Candidiasis; Chemical and Drug Induced Liver Injury; Drug Combinations; Female; Humans; Leukemia, Myeloid; Liver Diseases; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Splenic Diseases | 1999 |